Paces Ferry Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Paces Ferry Wealth Advisors, LLC
- $196 Million
- Q4 2024
A detailed history of Paces Ferry Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Paces Ferry Wealth Advisors, LLC holds 453 shares of REGN stock, worth $327,731. This represents 0.16% of its overall portfolio holdings.
Number of Shares
453
Previous 492
7.93%
Holding current value
$327,731
Previous $517,000
37.72%
% of portfolio
0.16%
Previous 0.3%
Shares
18 transactions
Others Institutions Holding REGN
# of Institutions
1,488Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.72 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.11 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.11 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.5 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.43 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $77.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...